Endoscopic Therapy in Primary Sclerosing Cholangitis. Dominant Strictures May Not Matter: Does that Mean that Endotherapy Does Not Work?

Kozarek, R. A.
March 2004
American Journal of Gastroenterology;Mar2004, Vol. 99 Issue 3, p509
Academic Journal
Comments on the use of endoscopic therapy as a treatment for primary sclerosing cholangitis. Complications of primary sclerosing cholangitis (PSC); Clinical studies demonstrating the efficacy of endotherapy; Effect of endotherapy on liver impairment associated with PSC.


Related Articles

  • Announcements.  // American Journal of Gastroenterology;May1991, Vol. 86 Issue 5, p657 

    Presents information on conferences and other activities related to the field of gastroenterology to be held from June to September 1991. 11th Annual Advances in Gastroenteroloy; Cellular and Molecular Bases of Liver Cirrhosis; Mayo-European Course in Gastroenterology.

  • Should We Use the Model for End-Stage Liver Disease (MELD) to Predict Mortality After Colorectal Surgery? Pantel, Haddon; Stensland, Kristian; Nelson, Jason; Francone, Todd; Roberts, Patricia; Marcello, Peter; Read, Thomas; Ricciardi, Rocco; Pantel, Haddon Jacob; Stensland, Kristian D; Francone, Todd D; Roberts, Patricia L; Marcello, Peter W // Journal of Gastrointestinal Surgery;Aug2016, Vol. 20 Issue 8, p1511 

    We sought to determine the accuracy of the Model for End-Stage Liver Disease and the Mayo Clinic Postoperative Mortality Risk in Patients with Cirrhosis Calculator in patients with ascites who underwent colorectal surgery. The National Surgical Quality Improvement Program database was queried...

  • Endoscopic Variceal Ligation Versus Endoscopic Injection Sclerotherapy: Comparison of Hepatic and Renal Function. Nakase, Hiroshi; Kawasaki, Toshihiko; Komori, Hideshi; Sakatani, Noriaki; Sawai, Shigeaki; Chiba, Tsutomu // American Journal of Gastroenterology;Oct1996, Vol. 91 Issue 10, p2170 

    Objectives: The aim of the present study was to compare the safety of endoscopic variceal ligation (EVL) and endoscopic injection sclerotherapy (EIS) in terms of liver and kidney functions in patients with liver cirrhosis. Methods: Forty-four patients admitted to Takatsuki General Hospital...

  • Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: A randomized controlled study. Dethloff, Thomas; Tofteng, Flemming; Frederiksen, Hans-Jorgen; Hojskov, Michael; Hansen, Bent Adel; Larsen, Fin Stolze; Reshetnyak, Vasiliy I.; Einarsson, Curt // World Journal of Gastroenterology;4/7/2008, Vol. 14 Issue 13, p2065 

    AIM: To evaluate treatment safety and hemodynamic changes during a single 6-h treatment with the Prometheusâ„¢ liver assist system in a randomized, controlled study. METHODS: Twenty-four patients were randomized to either the study group or to one of two control groups: Fractionated Plasma...

  • WHAT'S NEW IN Gl. Wisecarver, J. L.; Brand, R. E.; Roy, H. K.; Matamoros, A.; Thompson, Jon S. // American Journal of Gastroenterology;Jul1998, Vol. 93 Issue 7, p1025 

    Presents information on several studies related to gastroenterology. "Pancreatic Neuroendocrine Tumors: Benign or Malignant?"; "A Pure Cut May Be the Preferred Cut!"; "Another Reason for Caution in the Placement of a TIPS"; "Sick Liver-Sick Kidneys."

  • Dendroaspis Natriuretic Peptide in Hepatic Cirrhosis. Fábrega, Emilio; Crespo, Javier; Rivero, Montserrat; Casafont, Fernando; Castro, Beatriz; García-Unzueta, María Teresa; Amado, Jose Antonio; Pons-Romero, Fernando // American Journal of Gastroenterology;Sep2001, Vol. 96 Issue 9, p2724 

    OBJECTIVES: Dendroaspis natriuretic peptide (DNP) is a novel peptide that is structurally similar to atrial, brain, and C-type natriuretic peptides. Many natriuretic peptides are increased in hepatic cirrhosis, but the role of DNP in cirrhosis is unknown at present. The aim of the study was to...

  • Clinical Predictors of Large Esophageal Varices: How Accurate Are They? Ong, Janus; Younossi, Zobair M. // American Journal of Gastroenterology;Nov1999, Vol. 94 Issue 11, p3103 

    Provides a background of two studies featured in the November 1999 issue of the "American Journal of Gastroenterology" regarding the clinical features of large esophageal varices (LEV) in cirrhotic patients. Prevalence of LEV; Findings of the two studies; Limitations of the studies.

  • Obesity: The biggest cause of liver disease?  // Gastrointestinal Nursing;Nov2009, Vol. 7 Issue 9, p8 

    The article offers information on the poll conducted by the British Society of Gastroenterology (BSG) regarding the relationship between obesity and liver cirrhosis in Great Britain. The poll revealed that five out of six people do not know that overweight is related to liver disease. BSG...

  • Lymphatic Decompression Therapy of "Intractable" Ascites∗. Steigmann, F.; Long, D.; Mejicano, R. // American Journal of Gastroenterology;Jul1968, Vol. 50 Issue 1, p47 

    Presents a study on a therapy for the reduction of and prevention of the recurrence of ascites. Treatment for cirrhosis and ascites; Relationship between hepatic venous outflow block on lymphorrhea and ascites formation, and portal hypertension; Effect of cannulation of the thoracic duct.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics